← Leaderboards
Jason Scott McLellan
Avatar Medical, Llc
$14,153,484
Attributed
$18,491,632
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,491,632 · 8
By mechanism
U19$8,673,688 · 3
R01$8,080,627 · 3
P20$1,141,647 · 1
R43$595,670 · 1
Top collaborators
- Kartik Chandran5 shared
- Jennifer A Maynard5 shared
- Andrew Barrett Ward5 shared
- Roberto Mariani1 shared
- Mark Yondola1 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructureEpitopesAntibodiesVaccinesInsightVaccine AntigenNeutralizing AntibodyComplexMolecularMolecular ConformationCellsMortalityMorbidity - Disease RateBindingMediatingReceptorProtein EngineeringGlycoproteinsBaseDesignViralReagentInfection
Grant awards (26)
CORE C: Structure & Protein Engineering Core$2,042,293
U19 · FY2025 · AI · contact PI
Structure, function and antigenicity of B. pertussis virulence factors$564,342
R01 · FY2025 · AI · contact PI
CORE C: Structure & Protein Engineering Core$40,824
U19 · FY2025 · AI · contact PI
Core C: Structure Core$4,043,107
U19 · FY2024 · AI · contact PI
CORE C: Structure & Protein Engineering Core$847,709
U19 · FY2024 · AI · contact PI
Structure, function and antigenicity of B. pertussis virulence factors$564,342
R01 · FY2024 · AI · contact PI
Structure-based Vaccine Design for CCHFV$428,507
R01 · FY2024 · AI · contact PI
Structure, function and antigenicity of B. pertussis virulence factors$564,342
R01 · FY2023 · AI · contact PI
Structure-based Vaccine Design for CCHFV$428,507
R01 · FY2023 · AI · contact PI
Core E â Structural Biology$1,699,755
U19 · FY2022 · AI · contact PI
Structure, function and antigenicity of B. pertussis virulence factors$564,342
R01 · FY2022 · AI · contact PI
Structure-based Vaccine Design for CCHFV$428,507
R01 · FY2022 · AI · contact PI
Structure, Function and Antigenicity of Coronavirus Spike Proteins$613,032
R01 · FY2021 · AI · contact PI
Structure, function and antigenicity of B. pertussis virulence factors$564,342
R01 · FY2021 · AI · contact PI
Structure-based Vaccine Design for CCHFV$428,507
R01 · FY2021 · AI · contact PI
Structure, Function and Antigenicity of Coronavirus Spike Proteins$613,032
R01 · FY2020 · AI · contact PI
Structure-based Vaccine Design for CCHFV$441,966
R01 · FY2020 · AI · contact PI
Structure, Function and Antigenicity of Coronavirus Spike Proteins$613,032
R01 · FY2019 · AI · contact PI
Project 4: Molecular Mechanisms of RSV F Activation and Inhibition$267,764
P20 · FY2019 · GM · contact PI
Structure, Function and Antigenicity of Coronavirus Spike Proteins$627,157
R01 · FY2018 · AI · contact PI
Project 4: Molecular Mechanisms of RSV F Activation and Inhibition$330,417
P20 · FY2018 · GM · contact PI
Structure, Function and Antigenicity of Coronavirus Spike Proteins$636,670
R01 · FY2017 · AI · contact PI
Project 4: Molecular Mechanisms of RSV F Activation and Inhibition$275,702
P20 · FY2017 · GM · contact PI
Project 4: Molecular Mechanisms of RSV F Activation and Inhibition$267,764
P20 · FY2016 · GM · contact PI
Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine$296,818
R43 · FY2015 · AI
Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine$298,852
R43 · FY2014 · AI